Study Stopped
Boring and feared
Effect of TENS on Patients With Palmar Hyperhidrosis
Effect of Transcutaneous Electrical Nerve Stimulation on Patients With Palmar Hyperhidrosis
1 other identifier
interventional
56
1 country
1
Brief Summary
To investigate the effectiveness of Transcutaneous Electrical Nerve Stimulation on Hyperhidrosis Severity on patients with primary Palmar Hyperhidrosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2024
CompletedFirst Submitted
Initial submission to the registry
July 18, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedAugust 1, 2024
July 1, 2024
11 months
July 18, 2024
July 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change the severity of hyperhidrosis
Measure the rate sweating by iodine starch testin unit of score
2 weeks
Secondary Outcomes (1)
Change the quality of life
2 weeks
Study Arms (2)
TENS arm
EXPERIMENTALThis arm who was experimental group who received transcutaneous electrical nerve stimulation and breathing exercises
Breathing arm
SHAM COMPARATORThis arm was sham and not received official treatment
Interventions
TENS applied for 30 min for each time, five times a week, for 2 weeks and deep breathing relaxation exercise given to the intervention group twice a day (10min/exercise) for two weeks.
Eligibility Criteria
You may qualify if:
- Age range from 18 to 30 years old.
- Patients will be from both sexes.
- Body mass index from 18.5 to 24.9
- Subject suffer from primary palmar hyperhidrosis.
- No clinical treatment for palmar hyperhidrosis within the past month.
You may not qualify if:
- Patients outside the target range.
- Patients who were pregnant or lactating.
- Patients who had metal implants such as a pacemaker.
- Patients who had history of ischemic heart disease or arrhythmias.
- Patients who had any other diseases that could be the cause ofsecondary hyperhidrosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Mahmoud
Cairo, Cairo Government, 3753450, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amir Saleh, Professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor doctor
Study Record Dates
First Submitted
July 18, 2024
First Posted
August 1, 2024
Study Start
July 1, 2023
Primary Completion
May 16, 2024
Study Completion
May 16, 2024
Last Updated
August 1, 2024
Record last verified: 2024-07